Reading a panel

Is This An Eye Formula Or A Hair Formula?

Eight of the twenty-seven ingredients on this bottle are the standard contents of a hair and nails capsule, and the largest number on the whole panel belongs to one of them. That is not a scandal. It is a useful lesson in how to read any supplement label, and it changes what a buyer should reasonably expect.

By OptiCore Pro Team · Last updated October 29, 2026 · 8 min read · Label reading · Reviewed by Dr. Catherine Sheils, MD

Two shelves, two archetypes

Walk along any supplement aisle and the categories look distinct. Hair and nails on one shelf, eye health on another, joint support further down. Turn three bottles over and the panels start to blur, because a large part of the supplement market is built from the same few dozen commodity ingredients arranged into different stories.

The two archetypes below are what each category typically carries. No single bottle is exactly either of them, and setting a real panel against both is the fastest way to find out which story it is really telling.

Two archetypes, drawn from what each category typically carries rather than from any one brand. Real bottles sit somewhere between them.

The right-hand column deserves one qualification before it is used as a benchmark. Those amounts come from AREDS2 and its predecessor, which were run in people who already had age-related macular degeneration. The National Eye Institute publishes both formulations ingredient by ingredient, and neither is a recommendation for somebody with healthy eyes.

Where this panel actually sits

OptiCore Pro declares sixteen nutrients with a printed weight and a per cent Daily Value, plus a 179.5 mg blend naming eleven botanicals. Sorted against the two columns above, the result is not ambiguous.

The left column is read from the label artwork. The right column is what the published work on that ingredient used, and it is not a prediction about this capsule.

Read down that middle column and the pattern is clear. The ingredients with a real eye literature are present at a fraction of their trial amounts. The ingredients present in quantity, or present at all, mostly belong to a different shelf entirely. And the two that would settle the question in the other direction are absent.

That is a fair description of a broad multivitamin with a botanical blend, packaged and sold for the eye. It is a real product with a real use, and it is not the thing most buyers picture when they read the words on the front.

Why the same ingredients appear in both categories

There are three reasons, and only one of them is cynical.

The first is genuine overlap. Antioxidant nutrients act everywhere, and a vitamin that matters to the retina usually matters to the follicle too, because both are metabolically busy tissues. Vitamin C, vitamin E and zinc all appear across half the supplement market for that reason and their presence on an eye label is not suspicious.

The second reason is commercial and ordinary

Contract manufacturers hold a finite list of raw materials and a finite set of base formulas. A base carrying biotin, PABA, horsetail, bamboo and saw palmetto exists because the hair and nails category is enormous, and adapting an existing base is cheaper than formulating a new one. The result is a capsule whose backbone comes from one category and whose label comes from another.

The third is what regulation permits

A structure and function claim does not need the formula to match a trial. A bottle may say it supports eye health because its ingredients have a plausible role in ocular tissue, without any obligation to carry the amount a trial used. That is the rule for the whole industry rather than a loophole this product found, and it is why reading amounts matters more than reading claims.

The biotin figure, and what it is for

Two and a half milligrams of biotin is a specific number rather than an arbitrary one. It is the amount hair and nail capsules settled on decades ago, and it is roughly eighty-three times an adult Daily Value of 30 mcg.

The evidence behind it in its own category is thinner than the marketing suggests. A review of biotin for hair loss found eighteen reported cases in the entire literature, every one of them in somebody with an underlying cause of poor hair or nail growth. Biotin deficiency is real and correcting it works; supplementing a person who is not deficient is a different proposition.

In an eye context there is nothing at all. No trial has measured a vision outcome for biotin at any dose, and this desk searched rather than assuming.

The weight problem behind the blend

The eleven botanicals share 179.5 mg between them, listed in descending order with no figure for any single one. That format is legal and common, and its consequence here is arithmetic rather than legal.

Two of the eleven have well-known single-plant trials. Nettle root ran at 450 mg a day for twelve weeks. Saw palmetto ran at 320 mg a day for two years. Either figure on its own is larger than the entire blend. The plant sterols are further out still: the cholesterol literature works at roughly 2 g a day, more than eleven times the blend's whole weight.

• Eleven plants divide a total that is smaller than two of their individual trial doses.
• The descending order tells you PABA is the largest and barley grass the smallest, and nothing else.
• No plant inside the blend can be compared with a trial of that plant, because there is no figure to compare.
• Whatever the blend is doing, it is not reproducing any published single-plant result.

Three honest ways to read the result

A finding like this can be over-read in both directions, so here are the three defensible positions and what each one commits you to.

One: it is a broad multivitamin with an eye-shaped label

The most accurate description, and not a criticism. A daily multivitamin covering sixteen nutrients is a reasonable thing to take if your diet is narrow, and buying one that happens to be aimed at the eye costs nothing extra in nutritional terms. What it commits you to is dropping the expectation that it behaves like a trial formulation.

Two: the overlap is real and the framing is marketing

Also defensible. Vitamins A, C and E and zinc genuinely have roles in ocular tissue, and the label is entitled to say so. On this reading the hair-shelf ingredients are ballast rather than deception, and the question is whether you want to pay a category price for a commodity base.

Three: it is the wrong product for what you came for

If you arrived looking for the carotenoids AREDS2 is known for, this reading is the honest one. Lutein and zeaxanthin are absent, and no amount of reframing puts them on the panel. A dedicated lutein capsule costs less per day and carries the trial amounts.

Running the same check on any label

The method behind this article works on anything and takes about two minutes.

1. Find the largest proportional figure on the panel, which is the row with the biggest per cent Daily Value rather than the biggest milligram weight.
2. Ask which category that ingredient is famous in. If the answer is a different category from the one on the front of the bottle, you have learned something.
3. Count how many named ingredients sit inside a proprietary blend and how much of the bottle's weight they share.
4. Look for the two or three ingredients that define the category the label claims, and check whether they are present at all.
5. Compare the amounts that are present with the trial figures for those nutrients, which is what the vision supplement guide exists to supply.

The conclusion for this particular bottle is narrow and worth stating plainly. It is a competent broad multivitamin, honestly labelled in the sense that every declared amount is printed and every percentage computes correctly. It is not an AREDS-type eye formula, nobody should describe it as one, and a buyer who understands that is buying the right thing for the right reason.

The full panel is transcribed on the supplement facts page and each row is set beside its trial amount on the ingredients page.

References